Equator Therapeutics, Inc.

St. Louis, MO

UEI
ECUUHHN4LUB8
CAGE
8GZH1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
BioGenerator Labs, 4340 Duncan Ave Suite 201, St. Louis, MO 63110, USA
Website
equatortherapeutics.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Quick answers

Is Equator Therapeutics, Inc. registered in SAM.gov?

Yes. Equator Therapeutics, Inc.'s SAM.gov registration is active through June 17, 2027.

What is Equator Therapeutics, Inc.'s most recent federal award?

Equator Therapeutics, Inc.'s most recent federal grant award is Partial agonism of mitochondrial thermogenesis for the safe stimulation of energy expenditure (R43DK146576), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 1, 2026.

On GovTribe

See Equator Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors